Mirum Pharmaceuticals’ $445 Million Acquisition of Travere’s Bile Acid Product Portfolio

Leila Ahmed
Tagged:

Gibson, Dunn & Crutcher LLP is advising Mirum Pharmaceuticals, Cooley LLP is advising Travere Therapeutics, Inc. in the transaction.Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) and Travere Therapeutics,…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now